Treatment of osteoporosis: why, whom, when and how to treat

Ego Seeman and John A Eisman
Med J Aust 2004; 181 (5): . || doi: 10.5694/j.1326-5377.2004.tb06283.x
Published online: 6 September 2004

Ego Seeman,* John A Eisman†

  • 1 Austin Hospital, Studley Road, Heidelberg, VIC 3084.
  • 2 and Director, Bone and Mineral Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW.


Competing interests:

E S has been paid to sit on medical advisory boards for Aventis, Eli Lilly, and Merck Sharp & Dohme; J A E has been a paid consultant for Aventis, Eli Lilly, Merck Sharp & Dohme, NPS (USA), Organon, Roche and Servier.

  • 1. Dawson-Hughes B, Harris SS, Krall A, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 1997; 337: 670-676.
  • 2. Matkovic V, Kostial K, Simonovic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutrition 1979; 32: 540-549.
  • 3. Shea B, Wells G, Cranney A, et al. Osteoporosis Methodology Group; Osteoporosis Research Advisory Group. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 2004; 1: CD004526.
  • 4. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728-1733.
  • 5. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly people. Ann Intern Med 1996; 124: 400-406.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.